Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda’s Alunbrig beats Pfizer’s Xalkori on PFS in ALK positive NSCLC

pharmatimesJuly 27, 2018

Tag: Takeda , Xalkori , Crizotinib , Alunbrig

PharmaSources Customer Service